Global Blood Virus Testing Market Growth (Status and Outlook) 2023-2029

Global Blood Virus Testing Market Growth (Status and Outlook) 2023-2029

Viral testing is carried out to detect infections caused by viruses by destroying cells of immune system. Viruses breed only in living cells and cause diseases by destructing or injuring the cells they infect, damaging the body's whole immune system, altering the genetic material (DNA) of the cells they infect, or cause inflammation that can damage the complete organ. A viral infection can occur in different parts of the body such as intestine, respiratory tract and lungs. Common viral infections include common cold which is caused due to infection in the upper respiratory tract and influenza. Diagnostic virology is formulating diagnosis of viral disease and is moving rapidly mainstream in clinical medicine. Blood tests play a crucial role in diagnosing viral infections through various tests such as antibody testing, viral DNA or RNA detection tests. These test can show the exact virus causing an infection in the body.

LPI (LP Information)' newest research report, the “Blood Virus Testing Industry Forecast” looks at past sales and reviews total world Blood Virus Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Blood Virus Testing sales for 2023 through 2029. With Blood Virus Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Virus Testing industry.

This Insight Report provides a comprehensive analysis of the global Blood Virus Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Virus Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Virus Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Virus Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Virus Testing.

The global Blood Virus Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

Globally, there is rapid increase in number viral infections which are difficult to diagnose due to the nature of viruses which has surged the demand for viral testing. Blood virus testing has been proved to be successful in diagnosis of such viruses and thus blood virus testing market is estimated to represent colossal growth during the forecast period (2016-2024). Various research organizations such as Howard Hughes Medical Institute are working to develop one-stop-shop testing for viruses and have been successful recently. Improving research and medical facilities powered by technology is expected to develop new market opportunities for blood virus testing over the forecast years.

This report presents a comprehensive overview, market shares, and growth opportunities of Blood Virus Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Full Blood Count Test
Test for Inflammation
Immunology Test
Liver Function Test
VirScan Test

Segmentation by application
Hospitals
Diagnostic Centers
Clinics
Ambulatory Surgical Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
bioMérieux
Bio-Rad Laboratories
Thermo Fisher Scientific
Omega Diagnostics Group
Randox Laboratories
OraSure Technologies

Please note: The report will take approximately 2 business days to prepare and deliver.